<DOC>
	<DOCNO>NCT01317225</DOCNO>
	<brief_summary>The purpose study determine use 250 mg intramuscular progesterone biweekly reduce incidence preterm labor patient episode threatened preterm labor current pregnancy .</brief_summary>
	<brief_title>Prevention Preterm Labor Patients With Previous Episode Threatened Preterm Labor With Progesterone</brief_title>
	<detailed_description>Preterm birth one main cause neonatal mortality morbidity around world , serious repercussion health system family preterm baby . Many drug evaluate purpose prevent preterm birth patient risk . One drug 17 α hydroxyprogesterone caproate . The purpose study evaluate use biweekly dose 17 α hydroxyprogesterone caproate patient hospitalize diagnosis threaten preterm labor , define presence uterine contraction short cervix ( 10th percentile gestational age ) , reduce incidence preterm birth high risk group population .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>Pregnant woman 26 34 week gestation . Cervical length ( determined transvaginal ultrasound ) 10th percentile gestational age . Multiple gestation . Maternal pathology preterm termination pregnancy require .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Progesterone</keyword>
	<keyword>Obstetric labor , premature</keyword>
	<keyword>Short cervix</keyword>
</DOC>